Literature DB >> 9668074

Effects of glucose and insulin on rat apolipoprotein A-I gene expression.

K Murao1, Y Wada, T Nakamura, A H Taylor, A D Mooradian, N C Wong.   

Abstract

We have examined the regulation of apolipoprotein A-I (apoA-I) gene expression in response to glucose and insulin. In Hep G2 cells, endogenous apoA-I mRNA was suppressed by one-half or induced 2-fold following 48 h of exposure to high concentrations of glucose (22.4 mM) or insulin (100 microunits/ml), respectively, compared with control. Transcriptional activity of the rat apoA-I promoter (-474 to -7) in Hep G2 cells paralleled endogenous mRNA expression, and this activity was dependent on the dose of glucose or insulin. Deletional analysis showed that a 50-base pair fragment spanning -425 to -376 of the promoter mediated the effects of both insulin and glucose. Within this DNA fragment there is a motif (-411 to -404) that is homologous to a previously identified insulin response core element (IRCE). Mutation of this motif abolished not only the induction of the promoter by insulin but also abrogated its suppression by glucose. Electrophoretic mobility shift assay analysis of nuclear extracts from Hep G2 cells revealed IRCE binding activity that formed a duplex with radiolabeled probe. The IRCE binding activity correlated with insulin induction of apoA-I expression. In summary, our data show that glucose decreases and insulin increases apoA-I promoter activity. This effect appears to be mediated by a single cis-acting element.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9668074     DOI: 10.1074/jbc.273.30.18959

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

Review 1.  The emerging role of HDL in glucose metabolism.

Authors:  Brian G Drew; Kerry-Anne Rye; Stephen J Duffy; Philip Barter; Bronwyn A Kingwell
Journal:  Nat Rev Endocrinol       Date:  2012-01-24       Impact factor: 43.330

2.  Prolactin regulatory element binding protein as a potential transcriptional factor for the insulin gene in response to glucose stimulation.

Authors:  S Ohtsuka; K Murao; H Imachi; W M Cao; X Yu; J Li; H Iwama; N C W Wong; C Bancroft; T Ishida
Journal:  Diabetologia       Date:  2006-04-20       Impact factor: 10.122

Review 3.  Therapeutic interventions to enhance apolipoprotein A-I-mediated cardioprotection.

Authors:  Michael J Haas; Arshag D Mooradian
Journal:  Drugs       Date:  2010-05-07       Impact factor: 9.546

4.  Insulin-mediated down-regulation of apolipoprotein A5 gene expression through the phosphatidylinositol 3-kinase pathway: role of upstream stimulatory factor.

Authors:  Maxime Nowak; Audrey Helleboid-Chapman; Heidelinde Jakel; Geneviève Martin; Daniel Duran-Sandoval; Bart Staels; Edward M Rubin; Len A Pennacchio; Marja-Riitta Taskinen; Jamila Fruchart-Najib; Jean-Charles Fruchart
Journal:  Mol Cell Biol       Date:  2005-02       Impact factor: 4.272

5.  Apolipoprotein B mRNA editing and apolipoprotein gene expression in the liver of hyperinsulinemic fatty Zucker rats: relationship to very low density lipoprotein composition.

Authors:  M B Elam; M A von Wronski; L Cagen; F Thorngate; P Kumar; M Heimberg; H G Wilcox
Journal:  Lipids       Date:  1999-08       Impact factor: 1.880

Review 6.  Drug-subphenotype interactions for cancer in type 2 diabetes mellitus.

Authors:  Xilin Yang; Heung M Lee; Juliana C N Chan
Journal:  Nat Rev Endocrinol       Date:  2015-03-24       Impact factor: 43.330

7.  c-Jun N-terminal kinases inhibitor suppresses the TNF-alpha induced MCP-1 expression in human umbilical vein endothelial cells.

Authors:  Rania Abdel Muneem Ahmed; Koji Murao; Hitomi Imachi; Kazuya Yoshida; Hiroaki Dobashi; Naohisa Hosomi; Toshihiko Ishida
Journal:  Endocrine       Date:  2008-12-24       Impact factor: 3.633

8.  17β-Estradiol regulates scavenger receptor class BI gene expression via protein kinase C in vascular endothelial cells.

Authors:  Youko Fukata; Xiao Yu; Hitomi Imachi; Takamasa Nishiuchi; Jingya Lyu; Kayoko Seo; Akihiro Takeuchi; Hisakazu Iwama; Hisashi Masugata; Hiroshi Hoshikawa; Naohisa Hosomi; Yasumasa Iwasaki; Koji Murao
Journal:  Endocrine       Date:  2013-12-18       Impact factor: 3.633

9.  Apolipoprotein A-I stimulates AMP-activated protein kinase and improves glucose metabolism.

Authors:  R Han; R Lai; Q Ding; Z Wang; X Luo; Y Zhang; G Cui; J He; W Liu; Y Chen
Journal:  Diabetologia       Date:  2007-07-18       Impact factor: 10.122

10.  Low HDL cholesterol, metformin use, and cancer risk in type 2 diabetes: the Hong Kong Diabetes Registry.

Authors:  Xilin Yang; Wing Yee So; Ronald C W Ma; Alice P S Kong; Heung Man Lee; Linda W L Yu; Chun-Chung Chow; Risa Ozaki; Gary T C Ko; Juliana C N Chan
Journal:  Diabetes Care       Date:  2010-10-27       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.